Fidelity Investments’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.8K | Hold |
7,806
| – | – | ﹤0.01% | 4264 |
|
|
2025
Q1 | $62.7K | Sell |
7,806
-6,034
| -44% | -$48.5K | ﹤0.01% | 3758 |
|
|
2024
Q4 | $134K | Buy |
13,840
+335
| +2% | +$3.24K | ﹤0.01% | 3418 |
|
|
2024
Q3 | $251K | Buy |
13,505
+76
| +0.6% | +$1.41K | ﹤0.01% | 3116 |
|
|
2024
Q2 | $223K | Buy |
13,429
+1,610
| +14% | +$26.8K | ﹤0.01% | 2986 |
|
|
2024
Q1 | $205K | Sell |
11,819
-235,693
| -95% | -$4.09M | ﹤0.01% | 3020 |
|
|
2023
Q4 | $3.87M | Sell |
247,512
-173,465
| -41% | -$2.71M | ﹤0.01% | 2130 |
|
|
2023
Q3 | $20.8M | Buy |
420,977
+6,997
| +2% | +$346K | ﹤0.01% | 1573 |
|
|
2023
Q2 | $32.4M | Buy |
413,980
+93,561
| +29% | +$7.32M | ﹤0.01% | 1435 |
|
|
2023
Q1 | $29M | Buy |
320,419
+14,055
| +5% | +$1.27M | ﹤0.01% | 1461 |
|
|
2022
Q4 | $36.1M | Sell |
306,364
-10,411
| -3% | -$1.23M | ﹤0.01% | 1387 |
|
|
2022
Q3 | $57.5M | Buy |
316,775
+4,258
| +1% | +$773K | 0.01% | 1194 |
|
|
2022
Q2 | $28M | Sell |
312,517
-32,550
| -9% | -$2.92M | ﹤0.01% | 1516 |
|
|
2022
Q1 | $53.6M | Buy |
345,067
+24,151
| +8% | +$3.75M | ﹤0.01% | 1362 |
|
|
2021
Q4 | $95.5M | Buy |
320,916
+2,230
| +0.7% | +$664K | 0.01% | 1117 |
|
|
2021
Q3 | $184M | Buy |
318,686
+38,392
| +14% | +$22.1M | 0.01% | 843 |
|
|
2021
Q2 | $127M | Sell |
280,294
-22,265
| -7% | -$10.1M | 0.01% | 1017 |
|
|
2021
Q1 | $163M | Sell |
302,559
-9,508
| -3% | -$5.12M | 0.01% | 879 |
|
|
2020
Q4 | $270M | Buy |
312,067
+23,961
| +8% | +$20.7M | 0.02% | 627 |
|
|
2020
Q3 | $173M | Buy |
+288,106
| New | +$173M | 0.02% | 688 |
|